4893 items matching your search terms.

The world I want—a world with less diabetes

Jenkins, A.

Funding rates and grants trajectory

Jenkins, A.

Addressing vascular risk factors in diabetes

Jenkins, A.J. Januszewski, A.S. O'Neal, D.N.

Biomarkers in diabetic retinopathy

Jenkins, A. J. Joglekar, M. V. Hardikar, A. A. Keech, A. C. O’Neal, D. N. Januszewski, A. S.
REVIEW OF DIABETIC STUDIES, 2015     DOI:10.1900/RDS.2015.12.159

Fenofibrate and diabetic retinopathy [internet]

Jenkins, A.J. O'Neal, D. Keech, A.C.
, 2015     DOI:10.14496/dia.7105268810.13

Non-coding RNA biomarkers of diabetes complications

Joglekar, M. V. Hardikar, A. A. Farr, R. J. Januszewski, A. Evans, T. Satoor, S. Wong, W. Best, J. D. Yajnik, C. S. Blankenberg, S. Scott, R. Jenkins, A. Keech, A. C. Field Investigators

Development and piloting of a decision aid for women considering participation in the Sentinel Node Biopsy versus Axillary Clearance 2 breast cancer trial

Juraskova, I. Butow, P. Fisher, A. Bonner, C. Anderson, C. Bu, S. Scarlet, J. Stockler, M. R. Wetzig, N. Ung, O. Campbell, I.
CLINICAL TRIALS, 2015     DOI:10.1177/1740774515586404

Common sequence variation in the VEGFC gene is associated with diabetic retinopathy and diabetic macular edema

Kaidonis, G. Burdon, K. P. Gillies, M. C. Abhary, S. Essex, R. W. Chang, J. H. Pal, B. Pefkianaki, M. Daniell, M. Lake, S. Petrovsky, N. Hewitt, A. W. Jenkins, A. Lamoureux, E. L. Gleadle, J. M. Craig, J. E.
OPHTHALMOLOGY, 2015     DOI:10.1016/j.ophtha.2015.05.004

Addressing preference heterogeneity in public health policy by combining cluster analysis and multi-criteria decision analysis: proof of method

Kaltoft, M. K. Turner, R. Cunich, M. Salkeld, G. Nielsen, J. B. Dowie, J.
HEALTH ECONOMICS REVIEW, 2015     DOI:10.1186/s13561-015-0048-4

Interventions for lowering plasma homocysteine levels in kidney transplant recipients

Kang, A. Nigwekar, S. U. Perkovic, V. Kulshrestha, S. Zoungas, S. Navaneethan, S. D. Cass, A. Gallagher, M. P. Ninomiya, T. Strippoli, G. F. Jardine, M. J.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015     DOI:10.1002/14651858.CD007910.pub2

Personalised glucose therapy: glucose targets in critically ill patients with pre-existing poorly controlled type 2 diabetes

Kar, P. Plummer, M. P. Bellomo, R. Jenkins, A. J. Januszewski, A. S. Lange, K. Chapman, M. J. Horowitz, M. Deane, A. M.
INTENSIVE CARE MEDICINE EXPERIMENTAL, 2015     DOI:10.1186/2197-425x-3-s1-a290

Is it all about price? Why the Pharmaceutical Benefits Advisory Committee rejects submissions for listing anticancer drugs on the Pharmaceutical Benefits Scheme

Karikios, D. Chim, L. Martin, A. Nagrial, A. Salkeld, G. Howard, K. Stockler, M.

Is it all about price? Why anticancer drugs do not get recommended for government subsidy in Australia

Karikios, D. Chim, L. Martin, A. Nagrial, A. Salkeld, G. Howard, K. Stockler, M.

Discussing and prescribing expensive unfunded anticancer drugs in Australia

Karikios, D. Mileshkin, L. Martin, A. Ferraro, D. Stockler, M.

Osseointegrated total knee replacement connected to a lower limb prosthesis: 4 cases

Khemka, A. Frossard, L. Lord, S. J. Bosley, B. Al Muderis, M.
ACTA ORTHOPAEDICA, 2015     DOI:10.3109/17453674.2015.1068635